-
Mashup Score: 2
The 355 nm Auryon laser (AngioDynamics, Inc., Latham, New York) has been shown to be effective and safe in treating various morphology lesions in the femoropopliteal arteries. There are limited data on the Auryon laser in treating below-the-knee (BTK) arteries in patients with chronic limb-threateni …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease - 11 month(s) ago
/PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first…
Source: www.prnewswire.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10BD Registry Underscores Value of the Lutonix™ Drug Coated Balloon (DCB) Technology in Treating Femoropopliteal Disease - 1 year(s) ago
Results of the SAFE-DCB Registry support long-term safety and effectiveness for the Lutonix™ DCB in a real-world patient population with femoropopliteal disease.
Source: news.bd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Jetstream Atherectomy with Paclitaxel-Coated Balloons | VHRM - 2 year(s) ago
Presenting the 2-year outcome data of the JET-RANGER study, a randomized trial designed to demonstrate the superiority of Jetstream + Paclitaxel coated balloon
Source: www.dovepress.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Peripheral Arterial Interventions - 2 year(s) ago
This book examines new technologies (device and pharmacologic) that have evolved over the past few years in treating peripheral arterial disease.
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
The Flex VP is a longitudinal micro-incision catheter approved for vessel prepping of femoropopliteal arteries and arteriovenous fistulas. In this stu…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Auryon Laser in Treating Symptomatic Infrainguinal Arterial Disease: 1-Year Outcome - PubMed - 3 year(s) ago
In a realworld cohort of patient with complex disease, the Auryon laser had excellent freedom from TLR at 1 year.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
I will be discussing recent data that illustrate the importance of this dynamic interaction between precision imaging and vessel prepping.
Source: www.dovepress.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 01-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial - PubMed - 3 year(s) ago
In DEFINE PCI, despite angiographically successful PCI, highly symptomatic patients at baseline without residual ischemia by post-PCI iFR had greater reductions in anginal symptoms at 1 year compared with patients with residual ischemia. Achieving post-PCI iFR ≥0.95 was also associated with improved …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Amazon.com - 4 year(s) ago
Enter the characters you see below Sorry, we just need to make sure you’re not a robot. For best results, please make sure your browser is accepting cookies. …
Source: amazon.comCategories: Cardiologists, Latest HeadlinesTweet
Prospective, Multi-center, Single-Arm Study of the Auryon Laser System for Treatment of Below-the-Knee Arteries in … https://t.co/eYDcbtZyy4